251 related articles for article (PubMed ID: 2047605)
1. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of isoproterenol on quinidine induced torsade de pointes.
Yamamoto H; Bando S; Nishikado A; Shinohara A; Hamai K; Yamamoto K; Ikefuji H; Ito S
Tokushima J Exp Med; 1991 Jun; 38(1-2):1-4. PubMed ID: 1948996
[TBL] [Abstract][Full Text] [Related]
3. Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.
Bando S; Yamamoto H; Nishikado A; Hamai K; Fujino K; Nakaya Y; Shinohara A
Tokushima J Exp Med; 1990 Dec; 37(3-4):69-73. PubMed ID: 2094063
[TBL] [Abstract][Full Text] [Related]
4. [Torsade de pointes induced by quinidine: a case treated successfully with verapamil].
Ometto R; Arfiero S; Vincenzi M
G Ital Cardiol; 1990 May; 20(5):431-4. PubMed ID: 2210166
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
[TBL] [Abstract][Full Text] [Related]
7. [Iatrogenic torsade de pointes induced by thioridazine].
Paoloni P; Ciliberti D; Blasi N; Capone P
Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
[TBL] [Abstract][Full Text] [Related]
8. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
9. The use of isoproterenol and phenytoin to reverse torsade de pointes.
Omar HR; Sprenker C; Karlnoski R; Mangar D; Camporesi EM
Am J Emerg Med; 2014 Jun; 32(6):683.e5-7. PubMed ID: 24462399
[TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
Assimes TL; Malcolm I
Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy for torsade de pointes.
Banai S; Tzivoni D
J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
[TBL] [Abstract][Full Text] [Related]
12. [Magnesium sulphate in the treatment of torsade de pointes ventricular tachycardia].
Sangiorgi M; Fragola PV; Capria A
Ann Ital Med Int; 1988; 3(2):141-7. PubMed ID: 3152846
[No Abstract] [Full Text] [Related]
13. Torsade de pointes associated with encephalitis.
Alehan D; Ceviz N; Celiker A
Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105
[TBL] [Abstract][Full Text] [Related]
14. Treatment of torsade de pointes with intravenous magnesium in idiopathic long QT syndrome.
Hasegawa J; Takami T; Kaneda T; Yamane W; Hoshio A; Igawa O; Fujimoto Y; Kotake H; Mashiba H
Jpn Circ J; 1991 Nov; 55(11):1057-60. PubMed ID: 1749066
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
16. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.
Hoshino K; Ogawa K; Hishitani T; Isobe T; Etoh Y
Pediatr Int; 2006 Apr; 48(2):112-7. PubMed ID: 16635167
[TBL] [Abstract][Full Text] [Related]
17. [Short coupled variant of torsade de pointes: our experience and review of the literature].
Fehri W; Abdessalem S; Smiri Z; Mhenni H; Barakett N; Rahal N; Haouala H
Tunis Med; 2004 Sep; 82(9):867-74. PubMed ID: 15693481
[TBL] [Abstract][Full Text] [Related]
18. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
19. Female preponderance in ibutilide-induced torsade de pointes.
Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
[TBL] [Abstract][Full Text] [Related]
20. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
